Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.
The aims of this study were to analyse the expression of p53 by immunohistochemistry in a range of malignant and pre-malignant conditions and to assess the degree of inter-observer variability in interpretation of p53 immunostaining. Formalin-fixed paraffin-embedded sections from 28 colorectal carcinomas (CRC), 40 cervical intraepithelial neoplasia lesions (CIN), 22 transitional cell carcinomas of the bladder (TCC), 10 invasive squamous carcinomas of uterine cervix and 21 squamous cell carcinomas of skin were examined. A polyclonal antibody was used in 90 cases. A monoclonal antibody was used in the remainder. Ten cases were stained with both. Aberrant expression of p53 protein was documented in 48% of squamous cell carcinomas of skin, 29% of CRC, 22% of CIN and 23% of TCC. All cases of squamous cell carcinoma of uterine cervix were negative. Inter-observer variation occurred in 7% of cases examined. This was confined to two tumour groups, TCC and CIN. Our results showed that p53 oncoprotein expression by immunohistochemistry was identified in 26% of cases but the range was wide (0-48%) and appeared to be tumour specific. Inter-observer variability in the interpretation of immunohistochemical staining was low (7%) and was restricted to two tumour groups.
Kay
E W
EW
Department of Pathology, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin.
Barry Walsh
C J
CJ
Whelan
D
D
O'Grady
A
A
Leader
M B
MB
D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D009363:Neoplasm Proteins / Q000032:analysis; D009369:Neoplasms / Q000737:chemistry*; D015588:Observer Variation; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53